Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
- M. Miyamoto, H. Ojima, +8 authors T. Shibata
- Medicine
- British Journal of Cancer
- 14 June 2011
Background:Cholangiocarcinoma (CC) is a highly malignant carcinoma. We attempted to clarify the prognostic significance of c-Met overexpression and its association with clinicopathological factors in… Expand
Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
- D. Yoshikawa, H. Ojima, +4 authors T. Shibata
- Medicine
- British Journal of Cancer
- 24 March 2009
Cholangiocarcinoma is an intractable cancer, with no effective therapy other than surgical resection. Elevated vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR)… Expand
Assessment of contractility and myocardial function in small and appropriate for gestational age premature neonates using the stress-velocity relationship and tissue Doppler imaging immediately after…
- K. Miyamoto, Tatsuo Tsuboi, A. Kokubu, H. Suzumura, O. Arisaka
- Medicine
- Journal of pediatric endocrinology & metabolism…
- 1 October 2013
Abstract Our aim was to determine whether small for gestational age (SGA) neonates exhibit reduced left ventricular contractility and diastolic dysfunction, through the assessment of tissue by… Expand
Fluctuations in C-reactive protein in a hepatoblastoma patient with thrombocytosis
- Y. Sato, A. Kokubu, +7 authors T. Tsuchioka
- Medicine
- Clinics and practice
- 1 July 2011
We observed the changes in serum levels of interleukin 6 (IL-6) and C-reactive protein (CRP) in a patient with hepatoblastoma exhibiting thrombocytosis. The concomitant changes of IL-6 and CRP… Expand